Implications for risk assessment of host factors causing large pharmacokinetic variations
Normal human subjects vary widely in their capacity to eliminate many drugs and environmental chemicals. These variations range in magnitude from fourfold to fortyfold depending on the drug and the population studied. Pharmacogenetics deals with only one of many host factors responsible for these large pharmacokinetic differences. Age, sex, diet and exposure to other drugs and chemicals, including oral contraceptives, ethanol and cigarette smoking, can alter the genetically determined rate at which a particular subject eliminates drugs and environmental chemicals. These elimination rates, therefore, are dynamic and change even in the same subject with time and condition. Regulatory legislation has only recently begun to recognize this very broad spectrum of human susceptibility and the existence of multiple special subgroups of particularly sensitive subjects. In setting standards for environmental chemicals, EPA and NIOSH have attempted to protect the most sensitive humans and should be encouraged to continue this policy. For some drugs and environmental chemicals, the commonly used safety factor of 100 may be too low; for these chemicals large, interindividual pharmacokinetic variations produced by pharmacogenetic and other host factors may make a safety factor of 400 or 500 more adequate.
- Research Organization:
- Pennsylvania State Univ. College of Medicine, Hershey
- OSTI ID:
- 6168306
- Journal Information:
- Toxicol. Ind. Health; (United States), Vol. 1:4
- Country of Publication:
- United States
- Language:
- English
Similar Records
Human variability in susceptibility to toxic chemicals - a preliminary analysis of pharmacokinetic data from normal volunteers
Modeling interchild differences in pharmacokinetics on the basis of subject-specific data on physiology and hepatic CYP2E1 levels: A case study with toluene
Related Subjects
29 ENERGY PLANNING
POLICY AND ECONOMY
POLLUTANTS
HEALTH HAZARDS
MAXIMUM PERMISSIBLE EXPOSURE
RETENTION
BIOCHEMICAL REACTION KINETICS
BIOLOGICAL VARIABILITY
ENVIRONMENTAL POLICY
GENOTYPE
HUMAN POPULATIONS
NIOSH
RESPONSE MODIFYING FACTORS
RISK ASSESSMENT
SENSITIVITY
STANDARDS
US EPA
GOVERNMENT POLICIES
HAZARDS
KINETICS
NATIONAL ORGANIZATIONS
POPULATIONS
REACTION KINETICS
SAFETY STANDARDS
US ORGANIZATIONS
560300* - Chemicals Metabolism & Toxicology
290300 - Energy Planning & Policy- Environment
Health
& Safety